These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 22551039

  • 1. Patterns of case management and chemoprevention for malaria-in-pregnancy by public and private sector health providers in Enugu state, Nigeria.
    Onwujekwe OC, Soremekun RO, Uzochukwu B, Shu E, Onwujekwe O.
    BMC Res Notes; 2012 Jul 06; 5():211. PubMed ID: 22551039
    [Abstract] [Full Text] [Related]

  • 2. Perception and practice of malaria prophylaxis in pregnancy among health care providers in Ibadan.
    Onyeaso NC, Fawole AO.
    Afr J Reprod Health; 2007 Aug 06; 11(2):69-78. PubMed ID: 20690289
    [Abstract] [Full Text] [Related]

  • 3. Perception and practice of malaria prophylaxis in pregnancy among primary health care providers in Ibadan, Nigeria.
    Fawole AO, Onyeaso NC.
    West Afr J Med; 2008 Apr 06; 27(2):92-6. PubMed ID: 19025022
    [Abstract] [Full Text] [Related]

  • 4. Inequities in the use of sulphadoxine-pyrimethamine for malaria prophylaxis during pregnancy in Nigeria.
    Ndu A, Mbachu C, Anitube O, Ezeoke U.
    Malawi Med J; 2020 Mar 06; 32(1):45-51. PubMed ID: 32733659
    [Abstract] [Full Text] [Related]

  • 5. Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors.
    Onoka CA, Onwujekwe OE, Hanson K, Uzochukwu BS.
    Malar J; 2012 Sep 07; 11():317. PubMed ID: 22958539
    [Abstract] [Full Text] [Related]

  • 6. Intermittent use of sulphadoxine-pyrimethamine for malaria prevention: a cross-sectional study of knowledge and practices among Ugandan women attending an urban antenatal clinic.
    Odongo CO, Bisaso RK, Byamugisha J, Obua C.
    Malar J; 2014 Oct 11; 13():399. PubMed ID: 25306431
    [Abstract] [Full Text] [Related]

  • 7. Managing intermittent preventive treatment of malaria in pregnancy challenges: an ethnographic study of two Ghanaian administrative regions.
    Aberese-Ako M, Magnussen P, Gyapong M, Ampofo GD, Tagbor H.
    Malar J; 2020 Sep 25; 19(1):347. PubMed ID: 32977827
    [Abstract] [Full Text] [Related]

  • 8. Effect of group versus individual antenatal care on uptake of intermittent prophylactic treatment of malaria in pregnancy and related malaria outcomes in Nigeria and Kenya: analysis of data from a pragmatic cluster randomized trial.
    Noguchi L, Grenier L, Kabue M, Ugwa E, Oyetunji J, Suhowatsky S, Onguti B, Orji B, Whiting-Collins L, Adetiloye O.
    Malar J; 2020 Jan 29; 19(1):51. PubMed ID: 31996209
    [Abstract] [Full Text] [Related]

  • 9. Malaria prevention and treatment in pregnancy: survey of current practice among private medical practitioners in Lagos, Nigeria.
    Rabiu KA, Davies NO, Nzeribe-Abangwu UO, Adewunmi AA, Akinlusi FM, Akinola OI, Ogundele SO.
    Trop Doct; 2015 Jan 29; 45(1):6-11. PubMed ID: 25253668
    [Abstract] [Full Text] [Related]

  • 10. Health Workers' Awareness and Knowledge of Current Recommendation of Intermittent Preventive Treatment in Pregnancy in South-Western Nigeria.
    Bello OO, Oni O.
    Ethiop J Health Sci; 2020 Jan 29; 30(1):125-134. PubMed ID: 32116441
    [Abstract] [Full Text] [Related]

  • 11. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E, Berens-Riha N, Pritsch M, Nwachuku N, Loescher T, Meremikwu M.
    Malar J; 2018 Jul 06; 17(1):251. PubMed ID: 29976228
    [Abstract] [Full Text] [Related]

  • 12. Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria.
    Amoran OE, Ariba AA, Iyaniwura CA.
    Reprod Health; 2012 Aug 13; 9():12. PubMed ID: 22889320
    [Abstract] [Full Text] [Related]

  • 13. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: a preliminary study in Cape Coast Metropolis, Ghana.
    Amoako BK, Anto F.
    BMC Pregnancy Childbirth; 2021 Feb 02; 21(1):105. PubMed ID: 33530957
    [Abstract] [Full Text] [Related]

  • 14. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC, Chongwe G, Chipukuma H, Jacobs C, Zgambo J, Michelo C.
    BMC Pregnancy Childbirth; 2018 Apr 20; 18(1):108. PubMed ID: 29678150
    [Abstract] [Full Text] [Related]

  • 15. Effects of sulphadoxine-pyrimethamine on maternal, neonatal and placental malaria in Port Harcourt, Rivers State, Nigeria.
    Onoja H, Nduka F, Abah A.
    J Vector Borne Dis; 2023 Apr 20; 60(3):285-291. PubMed ID: 37843239
    [Abstract] [Full Text] [Related]

  • 16. Characteristics of Nigerian women taking sulfadoxine/pyrimethamine twice during pregnancy for the prevention of malaria.
    Onyeneho NG, Orji BC, Okeibunor JC, Brieger WR.
    Int J Gynaecol Obstet; 2013 Nov 20; 123(2):101-4. PubMed ID: 24041469
    [Abstract] [Full Text] [Related]

  • 17. Perspectives of health care providers on the provision of intermittent preventive treatment in pregnancy in health facilities in Malawi.
    Yoder PS, Nsabagasani X, Eckert E, Moran A, Yé Y.
    BMC Health Serv Res; 2015 Aug 29; 15():354. PubMed ID: 26318623
    [Abstract] [Full Text] [Related]

  • 18. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A, Jagannathan P, Kajubi R, Ochieng T, Ochokoru H, Nakalembe M, Clark TD, Ruel T, Staedke SG, Chandramohan D, Havlir DV, Kamya MR, Dorsey G.
    BMC Med; 2020 Aug 10; 18(1):207. PubMed ID: 32772921
    [Abstract] [Full Text] [Related]

  • 19. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC.
    BMC Public Health; 2020 Mar 16; 20(1):335. PubMed ID: 32178658
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting uptake of ≥ 3 doses of Sulfadoxine-Pyrimethamine for malaria prevention in pregnancy in selected health facilities, Arusha region, Tanzania.
    Mchwampaka WM, Tarimo D, Chacky F, Mohamed A, Kishimba R, Samwel A.
    BMC Pregnancy Childbirth; 2019 Nov 27; 19(1):440. PubMed ID: 31775686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.